{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:00:44Z","timestamp":1776106844670,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":90,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002744.pub2","type":"reference-entry","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T14:23:19Z","timestamp":1170771799000},"source":"Crossref","is-referenced-by-count":50,"title":["Neuraminidase inhibitors for preventing and treating influenza in children"],"prefix":"10.1002","author":[{"given":"Nicholas J","family":"Matheson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Harnden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mkael","family":"Symmonds-Abrahams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD002744.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0149-2918(02)80079-0","article-title":"Risk for respiratory events in a cohort of patients receiving inhaled zanamivir: a retrospective study","volume":"24","author":"Loughlin","year":"2002","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD002744.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.bmt.1704534","article-title":"Use of Oseltamivir to control influenza complications after bone marrow transplantation","volume":"34","author":"Machado","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD002744.pub2-BIB3|cit3","unstructured":"FDA 2003: US Food and Drug Administration: Center for Drug Evaluation and Research Relenza - Current Label http:\/\/www.fda.gov\/cder\/news\/relenza\/default.htm. 2003"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200005000-00005","article-title":"Zanamivir for treatment of symptomatic influenza A and B infection in children 5 to 12 years of age: a randomized controlled trial","volume":"19","author":"Hedrick 2000: Hedrick","year":"2000","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"5-6","key":"10.1002\/14651858.CD002744.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00228-003-0639-6","article-title":"Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years","volume":"59","author":"Oo","year":"2003","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0011-393X(00)88495-7","article-title":"Pharmacokinetics and tolerability of a single inhaled dose of zanamivir in children","volume":"61","author":"Peng","year":"2000","journal-title":"Current Therapeutic Research"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2165\/00002018-200326110-00004","article-title":"Safety and pharmacology of oseltamivir in clinical use","volume":"26","author":"Dutkowski 2003: Dutkowski","year":"2003","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD002744.pub2-BIB8|cit8","unstructured":"EMEA 2005: European Medicines Agency European Public Assessment Report: Tamiflu http:\/\/www.emea.eu.int\/humandocs\/Humans\/EPAR\/tamiflu\/tamiflu.htm 2005"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub2-BIB9|cit9","first-page":"421","article-title":"Erratum 2001","volume":"20","author":"Erratum","year":"2001","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD002744.pub2-BIB10|cit10","unstructured":"FDA 2004: US Food and Drug Administration: Center for Drug Evaluation and Research Tamiflu - Current Label http:\/\/www.fda.gov\/cder\/drug\/infopage\/tamiflu\/default.htm. 2004"},{"key":"10.1002\/14651858.CD002744.pub2-BIB11|cit11","series-title":"World Congress on Lung Health, Florence","article-title":"The impact of oseltamivir treatment on upper and lower respiratory tract complications of acute influenza in children","author":"Hayden 2000: Hayden","year":"2000"},{"key":"10.1002\/14651858.CD002744.pub2-BIB12|cit12","series-title":"10th European Congress of Clinical Microbiology and Infectious Diseases, Stockholm","article-title":"Oral oseltamivir is effective and safe in the treatment of children with acute influenza","author":"Reisinger 2000a: Reisinger","year":"2000"},{"key":"10.1002\/14651858.CD002744.pub2-BIB13|cit13","first-page":"250","article-title":"Oral oseltamivir is eective [sic] and safe in the treatment of children with acute influenza","volume":"6 (S1)","author":"Reisinger 2000b: Reisinger","year":"2000","journal-title":"Clinical Microbiology and Infection"},{"issue":"7","key":"10.1002\/14651858.CD002744.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00044011-200424070-00003","article-title":"Effect of Influenza Treatment with Oseltamivir on Health Outcome and Costs in Otherwise Healthy Children","volume":"24","author":"Reisinger 2004: Reisinger","year":"2004","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD002744.pub2-BIB15|cit15","series-title":"9th International Congress on Infectious Diseases, Buenos Aires","article-title":"Safety and acceptability of oseltamivir liquid formulation in the treatment of influenza in children aged 1 to 12 years","author":"Whitley 2000a: Whitley","year":"2000"},{"key":"10.1002\/14651858.CD002744.pub2-BIB16|cit16","series-title":"World Congress on Lung Health, Florence","article-title":"Oral oseltamivir is effective and safe in the treatment of influenza virus infections in children","author":"Whitley 2000b: Whitley","year":"2000"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"Whitley 2001: Whitley","year":"2001","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD002744.pub2-BIB18|cit18","series-title":"40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto","article-title":"Oral oseltamivir reduces the risk of developing acute otitis media following influenza infection in children","author":"Winther 2000: Winther","year":"2000"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2165\/00002018-200326110-00004","article-title":"Safety and Pharmacology of Oseltamivir in Clinical Use","volume":"26","author":"Dutkowski 2003: Dutkowski","year":"2003","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD002744.pub2-BIB20|cit20","unstructured":"EMEA 2005: European Medicines Agency European public assessment report: tamiflu http:\/\/www.emea.eu.int\/humandocs\/Humans\/EPAR\/tamiflu\/tamiflu.htm 2005"},{"key":"10.1002\/14651858.CD002744.pub2-BIB21|cit21","unstructured":"FDA 2004: US Food and Drug Administration: Center for Drug Evaluation and Research Tamiflu: current label http:\/\/www.fda.gov\/cder\/drug\/infopage\/tamiflu\/default.htm 2004"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.inf.0000154322.38267.ce","article-title":"Oral Oseltamivir Improves Pulmonary Function and Reduces Exacerbation Frequency for Influenza-Infected Children With Asthma","volume":"24","author":"Johnston 2005: Johnston","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD002744.pub2-BIB23|cit23","series-title":"9th International Congress on Infectious Diseases, Buenos Aires","article-title":"Safety and acceptability of oseltamivir liquid formulation in the treatment of influenza in children aged 1 to 12 years","author":"Whitley 2000a: Whitley","year":"2000"},{"key":"10.1002\/14651858.CD002744.pub2-BIB24|cit24","series-title":"41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago","article-title":"Effectiveness of oral oseltamivir in preventing spread of influenza-like illness in households with proven influenza","author":"Belshe 2001: Belshe","year":"2001"},{"key":"10.1002\/14651858.CD002744.pub2-BIB25|cit25","series-title":"42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California","article-title":"Oral Oseltamivir Prevents the Spread of Infleunza Between Children in Households","author":"Hayden 2002: Hayden","year":"2002"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/381128","article-title":"Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophlaxis","volume":"189","author":"Hayden 2004: Hayden","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub2-BIB27|cit27","first-page":"103","article-title":"Oseltamivir prophylaxis during the influenza seasion in a paediatric cancer centre: prospective observational study","volume":"10","author":"Chik","year":"2004","journal-title":"Hong Kong Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0149-2918(02)80082-0","article-title":"The effect of zanamivir treatment on influenza complications: a retrospective cohort study","volume":"24","author":"Cole","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/314440","article-title":"Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus","volume":"178","author":"Gubareva","year":"1998","journal-title":"The Journal of Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD002744.pub2-BIB30|cit30","first-page":"846","article-title":"Appropriate use of rapid diagnostic testing for influenza","volume":"78","author":"Hata","year":"2004","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002744.pub2-BIB31|cit31","first-page":"423","article-title":"Effectiveness of oseltamivir on influenza and influencing factors: age of patients, type of influenza virus and timing of initial administration","volume":"77","author":"Kawai","year":"2003","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"issue":"9436","key":"10.1002\/14651858.CD002744.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub2-BIB33|cit33","first-page":"946","article-title":"Effectiveness of oseltamivir treatment against influenza type A and type B infection in children","volume":"76","author":"Mitamura","year":"2002","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"key":"10.1002\/14651858.CD002744.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/345722","article-title":"Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households","volume":"186","author":"Monto","year":"2002","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD002744.pub2-BIB35|cit35","series-title":"39th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Inhaled zanamivir for preventing transmission of influenza in families","author":"Hayden","year":"1999"},{"issue":"18","key":"10.1002\/14651858.CD002744.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM200011023431801","article-title":"Inhaled zanamivir for preventing transmission of influenza in families. Zanamivir Family Study Group","volume":"343","author":"Hayden","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/135965350400900217","article-title":"Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study","volume":"9","author":"Nordstrom","year":"2004","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD002744.pub2-BIB38|cit38","unstructured":"Anonymous 2004 Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of oseltamivir in the treatment of influenza-mediated asthma symptoms in pediatric and adolescent patients with asthma Roche Clinical Trial Results Database (www.roche-trials.com) 2004"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00128072-200103030-00005","article-title":"Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children","volume":"3","author":"Oo","year":"2001","journal-title":"Paediatric Drugs"},{"key":"10.1002\/14651858.CD002744.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00430-002-0138-x","article-title":"Neuraminidase inhibitors in the management of influenza - experience of an outpatient practice","volume":"191","author":"Vogel","year":"2002","journal-title":"Medical Microbiology and Immunology"},{"key":"10.1002\/14651858.CD002744.pub2-BIB41|cit41","series-title":"16th World Congress of Family Doctors, Durban, South Africa","article-title":"Safety of oseltamivir in clinical use in children and adults","author":"Waskett","year":"2001"},{"issue":"6","key":"10.1002\/14651858.CD002744.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts. A randomized controlled trial","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD002744.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1248\/yakushi.123.887","article-title":"Investigation of the reconsultation rate and pharmacoeconomic evaluation of period of influenza treatment by oseltamivir","volume":"123","author":"Yamaura","year":"2003","journal-title":"Yakugaku Zasshi - Journal of the Pharmaceutical Society of Japan"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub2-BIB44|cit44","first-page":"971","article-title":"The study on efficacy of oseltamivir for influenza A in children","volume":"77","author":"Imamura","year":"2003","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB45|cit45","first-page":"262","article-title":"Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards","volume":"78","author":"Shinjoh","year":"2004","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"key":"10.1002\/14651858.CD002744.pub2-BIB46|cit46","first-page":"65","article-title":"Reducing influenza symptoms by 1.5 days a prospective randomized trial using the contingent valuation method to elicit preferences for neuraminidase inhibitors","author":"Bremen","year":"2003","journal-title":"Improving outcomes through Health Technology Assessment. 19th Annual Meeting of the International Society of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD002744.pub2-BIB47|cit47","unstructured":"Anonymous 2002 A double-blind, randomized, placebo-controlled, parallel-group, multicenter study to investigate the efficacy and safety of inhaled zanamivir 10 mg administered twice a day for five days in the treatment of symptomatic influenza A and B viral infections in children Glaxo Wellcome Clinical Trials Register (http:\/\/ctr.gsk.co.uk\/ArrchiveRegister) 2002"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00003495-199958050-00007","article-title":"Oseltamivir","volume":"58","author":"Bardsley-Elliot","year":"1999","journal-title":"Drugs"},{"issue":"20","key":"10.1002\/14651858.CD002744.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub2-BIB50|cit50","unstructured":"BioCryst Pharmaceuticals Inc Announces preliminary phase III trial results for influenza neuraminidase inhibitor, peramivir BioCryst Pharmaceuticals Investor Relations: News. (http:\/\/www.shareholder.com\/biocryst\/news\/20020625-83347.cfm) 2002"},{"key":"10.1002\/14651858.CD002744.pub2-BIB51|cit51","unstructured":"Brady B McAuley L Shukla VK Economic evaluation of zanamivir for the treatment of influenza. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2001 Technology Report No. 13 (available from http:\/\/www.ccohta.ca\/) 2001"},{"key":"10.1002\/14651858.CD002744.pub2-BIB52|cit52","first-page":"9","article-title":"Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation","volume":"6","author":"Burls","year":"2002","journal-title":"Health Technology Assessment (available from http:\/\/www.hta.nhsweb.nhs.uk)"},{"key":"10.1002\/14651858.CD002744.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archpedi.1995.02170230067009","article-title":"Influenza A vaccine decreases the incidence of acute otitis media in 6- to 30-month-old children in day care","volume":"149","author":"Clements","year":"1995","journal-title":"Archives of Pediatric and Adolescent Medicine"},{"issue":"7401","key":"10.1002\/14651858.CD002744.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.326.7401.1235","article-title":"Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: Systematic review and meta-analyses of randomised controlled trials","volume":"326","author":"Cooper","year":"2003","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1386-6532(99)00030-X","article-title":"Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children","volume":"13","author":"Freymuth","year":"1999","journal-title":"Journal of Clinical Virology"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM197803162981103","article-title":"Interpandemic influenza in the Houston area, 1974-76","volume":"298","author":"Glezen","year":"1978","journal-title":"The New England Journal of Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD002744.pub2-BIB57|cit57","first-page":"66","article-title":"Influenza virus and rhinovirus-related acute otitis media: potential for antiviral intervention","volume":"19","author":"Hayden","year":"2001","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD002744.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0531-5131(01)00358-2","article-title":"Influenza virus neuraminidase inhibitors: clinical aspects","volume":"1219","author":"Hayden","year":"2001","journal-title":"International Congress Series"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub2-BIB59|cit59","first-page":"445","article-title":"Influenza vaccination in the prevention of acute otitis media in children","volume":"145","author":"Heikkinen","year":"1991","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD002744.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJM199901283400402","article-title":"Prevalence of various respiratory viruses in the middle ear during acute otitis media","volume":"340","author":"Heikkinen","year":"1999","journal-title":"The New England Journal of Medicine"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD002744.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00006454-200005001-00004","article-title":"Role of viruses in the pathogenesis of acute otitis media","volume":"19","author":"Heikkinen","year":"2000","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD002744.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198206103062301","article-title":"A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion","volume":"306","author":"Henderson","year":"1982","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1086\/424572","article-title":"Viruses Resistant to the Antiviral Drug Oseltamivir: Transmission Studies in Ferrets","volume":"190","author":"Herlocher","year":"2004","journal-title":"The Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub2-BIB64|cit64","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.MR000001","article-title":"Time to publication for results of clinical trials","author":"Hopewell","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002744.pub2-BIB65|cit65","unstructured":"Husereau DR Brady B McGeer A Oseltamivir for the treatment of suspected influenza: a clinical and economic assessment. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2001 Technology Report No. 21 (available from http:\/\/www.ccohta.ca\/) 2001"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJM200001273420402","article-title":"Influenza and the rates of hospitalization for respiratory disease amongst infants and young children","volume":"342","author":"Izurieta","year":"2000","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub2-BIB68|cit68","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001169","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults","author":"Jefferson","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6989","key":"10.1002\/14651858.CD002744.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","article-title":"Community study of role of viral infections in exacerbations of asthma in 9-11 year old children","volume":"310","author":"Johnston","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002744.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archinte.161.2.212","article-title":"Zanamivir for the treatment of influenza A and B infection in high-risk patients","volume":"161","author":"Lalezari","year":"2001","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002744.pub2-BIB71|cit71","doi-asserted-by":"crossref","unstructured":"Lindbaek M Which children are in need of antibiotic treatment for acute otitis media? Electronic Letter to British Medical Journal (available from http:\/\/bmj.cin\/cgi\/eletter\/318\/7185\/715#2478) 1999","DOI":"10.1136\/bmj.318.7185.715"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/oxfordjournals.aje.a113356","article-title":"Estimating household and community transmission parameters for influenza","volume":"115","author":"Longini","year":"1982","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD002744.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Isolation of drug-resistant H5N1 virus","volume":"437","author":"Mai Le","year":"2005","journal-title":"Nature"},{"key":"10.1002\/14651858.CD002744.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1368-7646(98)80038-1","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"1","author":"Mendel","year":"1998","journal-title":"Drug Resistance Updates"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/AAC.49.11.4515-4520.2005","article-title":"Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors","volume":"49","author":"Mishin","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"13","key":"10.1002\/14651858.CD002744.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00044011-200020050-00005","article-title":"Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease","volume":"20","author":"Murphy","year":"2000","journal-title":"Clinical Drug Investigation"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200001273420401","article-title":"The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children","volume":"342","author":"Neuzil","year":"2000","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338363","article-title":"Burden of interpandemic influenza in children younger than 5 years: A 25-year prospective study","volume":"185","author":"Neuzil","year":"2002","journal-title":"The Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2222.1992.tb03094.x","article-title":"Viruses as precipitants of asthma symptoms. I. Epidemiology","volume":"22","author":"Pattemore","year":"1992","journal-title":"Clinical and Experimental Allergy"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00006454-200203000-00006","article-title":"Evaluation of diagnostic tests for influenza in a pediatric practice","volume":"21","author":"Rodriguez","year":"2002","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub2-BIB82|cit82","first-page":"256","article-title":"Presentation with influenza-like illness in general practice: implications for use of neuraminidase inhibitors","volume":"3","author":"Ross","year":"2000","journal-title":"Communicable Disease and Public Health"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub2-BIB83|cit83","first-page":"94","article-title":"Acute otitis media and respiratory virus infections","volume":"8","author":"Ruuskanen","year":"1989","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"7433","key":"10.1002\/14651858.CD002744.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bmj.328.7433.227","article-title":"Guidelines on neuraminidase inhibitors in children are not supported by evidence","volume":"328","author":"Symmonds","year":"2004","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002744.pub2-BIB85|cit85","doi-asserted-by":"crossref","unstructured":"Turner D Wailoo A Nicholson K Cooper N Sutton A Abrams K Systematic review and economic decision modelling for the prevention and treatment of influenza A and B Health Technology Assessment (available from http:\/\/www.nice.org.uk\/docref.asp?d=35650) 2002","DOI":"10.3310\/hta7350"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/clinids\/20.3.521","article-title":"Risk of acute otitis media in relation to the viral etiology of infections in children","volume":"20","author":"Uhari","year":"1995","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD002744.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM200003023420914","article-title":"Respiratory distress associated with zanamivir","volume":"342","author":"Williamson","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.49.10.4075-4084.2005","article-title":"Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility","volume":"49","author":"Yen","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD002744.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/S0140-6736(01)06528-X","article-title":"Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study","volume":"358","author":"Zambon","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0166-3542(01)00124-3","article-title":"Position statement: global neuraminidase inhibitor susceptibility network","volume":"49","author":"Zambon","year":"2001","journal-title":"Antiviral Research"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002744.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T13:02:35Z","timestamp":1683723755000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002744.pub2"}},"subtitle":[],"editor":[{"given":"Nicholas J","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":90,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002744.pub2","relation":{},"subject":[],"published":{"date-parts":[[2007,1,24]]}}}